Российский консенсус по профилактике, диагностике и лечению рака желудка. Вопросы инструментальной диагностики

   Российский консенсус по профилактике, диагностике и лечению рака желудка подготовлен по инициативе Московского клинического научного центра им А. С. Логинова ДЗМ по Дельфийской системе. 

   Его целью явилась консолидация мнений отечественных специалистов по наиболее актуальным вопросам профилактики, скрининга, диагностики и лечения рака желудка. 

   Междисциплинарный подход обеспечен участием ведущих гастроэнтерологов, онкологов и хирургов. В данной статье представлены ключевые нерешенные вопросы хирургического лечения рака желудка, а также позиции Российского консенсуса по ним.

   Цель статьи: Представить положения Российского консенсуса по профилактике, диагностике и лечению рака желудка, касающиеся аспектов инструментальной диагностики.

1. Smyth E.C., Verheij M., Allum W., et al. ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27(suppl 5):v38-v49. doi: 10.1093/annonc/mdw350

2. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5^th edition). Gastric Cancer 2021;24(1):1–21. doi: 10.1007/s10120-020-01041-y

3. NCCN Clinical Practice Guideline in. Gastric Cancer version 3.2020. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf

4. Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multidisciplinary Approach. J Gastric Cancer. 2019 Mar;19(1):1–48. doi: 10.5230/jgc.2019.19.e8. Epub 2019 Mar 19. Erratum in: J Gastric Cancer. 2019 Sep;19(3):372–373

5. Matsumura S., Dohi O., Yamada N, et al. Improved visibility of early gastric cancer after successful Helicobacter pylori eradication with image-enhanced endoscopy: A multi-institutional study using video clips. J Clin Med 2021;10(16):3649. doi: 10.3390/jcm10163649

6. Kawahara Y., Takenaka R., Okada H., et al. Novel chromoendoscopic method using an acetic acid-indigocarmine mixture for diagnostic accuracy in delineating the margin of early gastric cancers. Dig Endosc 2009;21(1):14–9. doi: 10.1111/j.1443-1661.2008.00824.x

7. Matsumoto Y., Yanai H., Tokiyama H., et al. Endoscopic ultrasonography for diagnosis of submucosal invasion in early gastric cancer. J Gastroenterol 2000;35(5):326–31. doi: 10.1007/s005350050356

8. Puli S.R., Batapati Krishna Reddy J., Bechtold M.L., et al. How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review. World J Gastroenterol 2008;14(25):4011–9. doi: 10.3748/wjg.14.4011

9. Bergman J.J., Fockens P. Endoscopic ultrasonography in patients with gastro-esophageal cancer. Eur J Ultrasound 1999;10(2–3):127–38. doi: 10.1016/s0929-8266(99)00055-5

10. Lee K.G., Shin C.I., Kim S.G., et al. Can endoscopic ultrasonography (EUS) improve the accuracy of clinical T staging by computed tomography (CT) for gastric cancer? Eur J Surg Oncol 2021;47(8):1969–1975. doi: 10.1016/j.ejso.2021.02.031

11. Kaurah P., Huntsman D.G. Hereditary Diffuse Gastric Cancer. 2002 Nov 4 [updated 2018 Mar 22. In: Adam M.P., Ardinger H.H., Pagon R.A., et al. editors. GeneReviews® Internet. Seattle (WA): University of Washington, Seattle; 1993–2022

12. Cha R.R., Cho J.K., Kim W.S., et al. Primary gastric small cell carcinoma (presenting as linitis plastica) diagnosed using endoscopic ultrasound-guided biopsy: a case report. Clin Endosc 2019;52(3):278–282. doi: 10.5946/ce.2018.114

13. Jung K., Park M.I., Kim S.E., Park S.J. Borrmann type 4 advanced gastric cancer: focus on the development of scirrhous gastric cancer. Clin Endosc 2016;49(4):336–45. doi: 10.5946/ce.2016.057

14. Morgant S., Artru P., Oudjit A., et al. Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study. Ann Transl Med 2021;9(1):50. doi: 10.21037/atm-20-3474

15. Qiu H., Zhou Z. Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5. Zhonghua Wei Chang Wai Ke Za Zhi 2018;21(2):160–164

16. Cardoso R., Coburn N., Seevaratnam R., et al. A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer. Gastric Cancer 2012;15 Suppl 1:S19–26. doi: 10.1007/s10120-011-0115-4

17. Smyth E.C., Verheij M., Allum W., et al. ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27(suppl 5):v38-v49. doi: 10.1093/annonc/mdw350

18. Bentrem D., Gerdes H, Tang L, Brennan M, Coit D. Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer. Ann Surg Oncol 2007;14(6):1853–9. doi: 10.1245/s10434-006-9037-5

19. Lee M.H., Choi D., Park M.J., Lee M.W. Gastric cancer: imaging and staging with MDCT based on the 7^th AJCC guidelines. Abdom Imaging 2012;37(4):531–40. doi: 10.1007/s00261-011-9780-3

20. Guniganti P., Bradenham C.H., Raptis C., et al. CT of Gastric Emergencies. Radiographics. 2015;35(7):1909–21. doi: 10.1148/rg.2015150062

21. Агабабян Т.А. Диагностика внеорганного распространения рака желудка (категория Т) методом мультиспиральной компьютерной томографии: анализ ошибок. Медицинская визуализация. 2012;3:33–40

22. Shimizu K., Ito K., Matsunaga N., et al. Diagnosis of gastric cancer with MDCT using the water-filling method and multiplanar reconstruction: CT-histologic correlation. AJR Am J Roentgenol 2005;185(5):1152–8. doi: 10.2214/AJR.04.0651

23. Park H.S., Kim Y.J., Ko S.Y., et al. Benign regional lymph nodes in gastric cancer on multidetector row CT. Acta Radiol 2012;53(5):501–7. doi: 10.1258/ar.2012.120054

24. Wei W.Z., Yu J.P., Li J., et al. Evaluation of contrast-enhanced helical hydro-CT in staging gastric cancer. World J Gastroenterol 2005;11(29):4592–5. doi: 10.3748/wjg.v11.i29.4592

25. Seevaratnam R., Cardoso R., McGregor C., et al. How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer 2012;15 Suppl 1:S3–18. doi: 10.1007/s10120-011-0069-6

26. Hu Y.F., Deng Z.W., Liu H., et al. Staging laparoscopy improves treatment decision-making for advanced gastric cancer. World J Gastroenterol. 2016;22(5):1859–68. doi: 10.3748/wjg.v22.i5.1859

27. Jang G.S., Kim M.J., Ha H.I., et al. Comparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer. Chin J Cancer Res 2013;25(6):689–94. doi: 10.3978/j.issn.1000-9604.2013.11.09

28. Xu X., Zheng G., Zhang T., et al. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response. Cancer Chemother Pharmacol 2019;84(3):635–646. doi: 10.1007/s00280-019-03893-4

29. Kim J.H., Heo S.H., Kim J.W., et al. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography. World J Gastroenterol 2017;23(35):6448–6456. doi: 10.3748/wjg.v23.i35.6448

30. Kim D.W., Park S.A., Kim C.G. Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT. J Korean Med Sci 2011;26(7):875–80. doi: 10.3346/jkms.2011.26.7.875

31. Kim S.K., Kang K.W., Lee J.S., et al. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006;33(2):148–55. doi: 10.1007/s00259-005-1887-8

32. Wu C.X., Zhu Z.H. Diagnosis and evaluation of gastric cancer by positron emission tomography. World J Gastroenterol 2014;20(16):4574–85. doi: 10.3748/wjg.v20.i16.4574

33. Yun M. Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT. J Gastric Cancer 2014;14(1):1–6. doi: 10.5230/jgc.2014.14.1.1

34. Park M.J., Lee W.J., Lim H.K., et al. Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom Imaging 2009;34(4):441–7. doi: 10.1007/s00261-008-9424-4

35. Zou H., Zhao Y. 18FDG PET-CT for detecting gastric cancer recurrence after surgical resection: a meta-analysis. Surg Oncol 2013;22(3):162–6. doi: 10.1016/j.suronc.2013.05.001

36. De Potter T., Flamen P., Van Cutsem E., et al. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging. 2002;29(4):525–9. doi: 10.1007/s00259-001-0743-8

37. Liu N.B., Zhu L., Li M.H., et al. Diagnostic value of 18F-FDG PET/CT in comparison to bone scintigraphy, CT and 18F-FDG PET for the detection of bone metastasis. Asian Pac J Cancer Prev 2013;14(6):3647–52. doi: 10.7314/apjcp.2013.14.6.3647.